Cargando…

Risk Factors and Impact of non-Aspergillus mold infections (NAMI) following Allogeneic HCT: A CIBMTR Infection & Immune Reconstitution analysis

Risk factors for non-Aspergillus mold infection (NAMI) and the impact on transplant outcome are poorly assessed in the current era of antifungal agents. Outcomes of 124 patients receiving allogeneic HCT diagnosed with either mucormycosis [n=72] or fusariosis [n=52] between days 0-365 after HCT are d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riches, Marcie L., Trifilio, Steven, Chen, Min, Ahn, Kwang Woo, Langston, Amelia, Lazarus, Hillard M., Marks, David I., Martino, Rodrigo, Maziarz, Richard T., Papinicolou, Genofeva A., Wingard, John R., Young, Jo-Anne H., Bennett, Charles L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4740251/ https://www.ncbi.nlm.nih.gov/pubmed/26524262 http://dx.doi.org/10.1038/bmt.2015.263

Ejemplares similares

Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR(®) study
por: Maziarz, Richard T., et al.
Publicado: (2016)

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR NEUROBLASTOMA: THE CIBMTR EXPERIENCE
por: Hale, Gregory A., et al.
Publicado: (2013)

Clinical Outcomes of Patients with Desmoplastic Small Round Cell Tumor of the Peritoneum Undergoing Autologous HCT: a CIBMTR Retrospective Analysis
por: Cook, Rachel J., et al.
Publicado: (2012)

COVID-19 in Pediatric Hematopoietic Cell Transplant Recipients: A CIBMTR Study
por: Bhatt, Neel S., et al.
Publicado: (2021)

Age is no Barrier for Adults undergoing HCT for AML in CR1: Contemporary CIBMTR Analysis
por: Maakaron, Joseph E., et al.
Publicado: (2022)

Incidence and Impact of Community Respiratory Viral Infection (CRV) in Haploidentical and Matched Sibling Donors Receiving Post-Transplant Cyclophosphamide (PTCy): A CIBMTR Analysis
por: Taplitz, Randy, et al.
Publicado: (2020)

The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR(®) analysis
por: Williams, Kirsten M., et al.
Publicado: (2016)

PROGNOSTIC FACTORS FOR OUTCOMES IN ALLOGENEIC TRANSPLANTATION FOR ADVANCED PHASES OF CHRONIC MYELOID LEUKEMIA IN THE IMATINIB ERA: A CIBMTR ANALYSIS
por: Khoury, Hanna J, et al.
Publicado: (2011)

COVID-19 in Hematopoietic Cell Transplant Recipients: A CIBMTR Study
por: Sharma, Akshay, et al.
Publicado: (2021)

Gamma delta T-cell reconstitution after allogeneic HCT: A platform for cell therapy
por: Gaballa, Ahmed, et al.
Publicado: (2022)

Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis
por: Murthy, Hemant S., et al.
Publicado: (2023)

A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis
por: Tamari, Roni, et al.
Publicado: (2023)

Biomarkers for Allogeneic HCT Outcomes
por: Adom, Djamilatou, et al.
Publicado: (2020)

PtyNAMi: ptychographic nano-analytical microscope
por: Schropp, Andreas, et al.
Publicado: (2020)

NMDP/CIBMTR donor selection guidelines
Publicado: (2019)

Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma: a CIBMTR analysis
por: Epperla, Narendranath, et al.
Publicado: (2019)

A Timely CIBMTR Analysis of How Cryopreservation Impacts Allogeneic Hematopoietic Cell Transplantation to Apply in the COVID Era
por: Allan, David S.
Publicado: (2021)

IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation
por: Betts, Brian C., et al.
Publicado: (2017)

Maintenance therapy for AML after allogeneic HCT
por: Nayak, Rahul K., et al.
Publicado: (2022)

The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis
por: Mei, Matthew, et al.
Publicado: (2022)

Hypoxia-selective inhibition of angiogenesis development by NAMI-A analogues
por: Oszajca, Maria, et al.
Publicado: (2016)

Enhancer RNAs: transcriptional regulators and workmates of NamiRNAs in myogenesis
por: Odame, Emmanuel, et al.
Publicado: (2021)

Inhibition of endothelial cell functions and of angiogenesis by the metastasis inhibitor NAMI-A
por: Vacca, A, et al.
Publicado: (2002)

Steering Against Wind: A New Network of NamiRNAs and Enhancers
por: Liang, Ying, et al.
Publicado: (2017)

Abstract 2 Results of an Open Label Expanded Access Study of Omidubicel-onlv for Allogeneic Transplantation (allo-HCT) in Patients with Hematologic Malignancies
por: Horwitz, Mitchell, et al.
Publicado: (2023)

DyNAMiC Workbench: an integrated development environment for dynamic DNA nanotechnology
por: Grun, Casey, et al.
Publicado: (2015)

Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting
por: Pfeiffer, Thomas, et al.
Publicado: (2023)

The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies
por: Passweg, Jakob R., et al.
Publicado: (2019)

Whole-Body Counter(WBC) and food radiocesium contamination surveys in Namie, Fukushima Prefecture
por: Hosokawa, Yoichiro, et al.
Publicado: (2017)

Reactivation of tumour suppressor in breast cancer by enhancer switching through NamiRNA network
por: Liang, Ying, et al.
Publicado: (2021)

Humoral Immunogenicity of Sars-Cov-2 Vaccination in the First Year after Hematopoietic Cell Transplant or Chimeric Antigen Receptor T Cell Therapy: A CIBMTR and BMT CTN Study
por: Riches, Marcie L., et al.
Publicado: (2022)

A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT
por: Schäfer, Henning, et al.
Publicado: (2021)

Early Respiratory Viral Acquisition after Allogeneic Hematopoietic Cell Transplant (HCT)
por: Boonyaratanakornkit, Jim, et al.
Publicado: (2019)

Assessment of Serology after Sars-Cov-2 Vaccine in Allogeneic HCT Recipients
por: Baker, Melissa, et al.
Publicado: (2021)

Impact of low- and high-molecular-mass components of human serum on NAMI-A binding to transferrin
por: Śpiewak, K., et al.
Publicado: (2015)

Transition of Radioactive Cesium Deposition in Reproductive Organs of Free-Roaming Cats in Namie Town, Fukushima
por: Fujishima, Yohei, et al.
Publicado: (2021)

Electronic structure and mechanism for the uptake of nitric oxide by the Ru(iii) antitumor complex NAMI-A
por: Pereira, Eufrásia S., et al.
Publicado: (2021)

A Mortality Analysis of the Cytomegalovirus (CMV) Infection Letermovir Prophylaxis Trial in CMV-Seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation (HCT)
por: Maertens, Johan, et al.
Publicado: (2017)

Unfavorable transcriptome profiles and social disadvantage in hematopoietic cell transplantation: a CIBMTR analysis
por: Taylor, Mallory R., et al.
Publicado: (2023)

Real-Life Considerations on Antifungal Treatment Combinations for the Management of Invasive Mold Infections after Allogeneic Cell Transplantation
por: Glampedakis, Emmanouil, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ocr29rbj4glo7lj0do3olkrjs5